Cargando…

Comparison of two soft-agar methods for assaying chemosensitivity of human tumours in vitro: malignant melanomas.

Two soft-agar methods for assaying chemosensitivity of human cancers in vitro were compared with respect to colony morphology, plating efficiency (PE) and chemosensitivity of human melanomas. In 9 xenografts and 9 patients' biopsy specimens Method A (essentially that of Courtenay & Mills, 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Tveit, K. M., Endresen, L., Rugstad, H. E., Fodstad, O., Pihl, A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1981
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010803/
https://www.ncbi.nlm.nih.gov/pubmed/7295510
_version_ 1782136398473592832
author Tveit, K. M.
Endresen, L.
Rugstad, H. E.
Fodstad, O.
Pihl, A.
author_facet Tveit, K. M.
Endresen, L.
Rugstad, H. E.
Fodstad, O.
Pihl, A.
author_sort Tveit, K. M.
collection PubMed
description Two soft-agar methods for assaying chemosensitivity of human cancers in vitro were compared with respect to colony morphology, plating efficiency (PE) and chemosensitivity of human melanomas. In 9 xenografts and 9 patients' biopsy specimens Method A (essentially that of Courtenay & Mills, 1978) gave considerably higher PE that Method B (essentially that of Hamburger & Salmon, 1977) and, in contrast to Method B, the number of colonies was proportional to the number of cells plated. Evidence was obtained that the observed differences in PE could be attributed to the low O2 concentration and the presence of rat red blood cells in Method A. Colony morphology was similar in the 2 assays. When cells from 4 xenografted melanomas were treated in vitro with DTIC, CCNU, vinblastine and abrin, and the inhibition of colony formation was assayed concurrently in the 2 soft-agar methods, the tumour cells appeared to be more sensitive to 3 of the drugs in Method B than in A. The results demonstrate that chemosensitivity data obtained with the 2 assays cannot be directly compared.
format Text
id pubmed-2010803
institution National Center for Biotechnology Information
language English
publishDate 1981
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20108032009-09-10 Comparison of two soft-agar methods for assaying chemosensitivity of human tumours in vitro: malignant melanomas. Tveit, K. M. Endresen, L. Rugstad, H. E. Fodstad, O. Pihl, A. Br J Cancer Research Article Two soft-agar methods for assaying chemosensitivity of human cancers in vitro were compared with respect to colony morphology, plating efficiency (PE) and chemosensitivity of human melanomas. In 9 xenografts and 9 patients' biopsy specimens Method A (essentially that of Courtenay & Mills, 1978) gave considerably higher PE that Method B (essentially that of Hamburger & Salmon, 1977) and, in contrast to Method B, the number of colonies was proportional to the number of cells plated. Evidence was obtained that the observed differences in PE could be attributed to the low O2 concentration and the presence of rat red blood cells in Method A. Colony morphology was similar in the 2 assays. When cells from 4 xenografted melanomas were treated in vitro with DTIC, CCNU, vinblastine and abrin, and the inhibition of colony formation was assayed concurrently in the 2 soft-agar methods, the tumour cells appeared to be more sensitive to 3 of the drugs in Method B than in A. The results demonstrate that chemosensitivity data obtained with the 2 assays cannot be directly compared. Nature Publishing Group 1981-10 /pmc/articles/PMC2010803/ /pubmed/7295510 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Tveit, K. M.
Endresen, L.
Rugstad, H. E.
Fodstad, O.
Pihl, A.
Comparison of two soft-agar methods for assaying chemosensitivity of human tumours in vitro: malignant melanomas.
title Comparison of two soft-agar methods for assaying chemosensitivity of human tumours in vitro: malignant melanomas.
title_full Comparison of two soft-agar methods for assaying chemosensitivity of human tumours in vitro: malignant melanomas.
title_fullStr Comparison of two soft-agar methods for assaying chemosensitivity of human tumours in vitro: malignant melanomas.
title_full_unstemmed Comparison of two soft-agar methods for assaying chemosensitivity of human tumours in vitro: malignant melanomas.
title_short Comparison of two soft-agar methods for assaying chemosensitivity of human tumours in vitro: malignant melanomas.
title_sort comparison of two soft-agar methods for assaying chemosensitivity of human tumours in vitro: malignant melanomas.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010803/
https://www.ncbi.nlm.nih.gov/pubmed/7295510
work_keys_str_mv AT tveitkm comparisonoftwosoftagarmethodsforassayingchemosensitivityofhumantumoursinvitromalignantmelanomas
AT endresenl comparisonoftwosoftagarmethodsforassayingchemosensitivityofhumantumoursinvitromalignantmelanomas
AT rugstadhe comparisonoftwosoftagarmethodsforassayingchemosensitivityofhumantumoursinvitromalignantmelanomas
AT fodstado comparisonoftwosoftagarmethodsforassayingchemosensitivityofhumantumoursinvitromalignantmelanomas
AT pihla comparisonoftwosoftagarmethodsforassayingchemosensitivityofhumantumoursinvitromalignantmelanomas